Glenmark turns to ERD to support growth

The generic pharmaceutical landscape is a complex, highly regulated market, where companies must keep a keen eye on revenue margins. Any generics company looking to grow must take a proactive approach to pricing execution to handle expanding volumes of sales. And any solution that manages this automatically has to be flexible enough to grow with the company.

As a customer for more than eight years, generic pharmaceutical company Glenmark Generics Inc., the U.S. division of Glenmark Generics Ltd., turned to us for a flexible solution to fit its contract, pricing, and compliance strategies, all within budget.

Check out our press release that details how Revitas Flex will enable Glenmark Generics Inc. to enforce effective sales contracting strategies and protect revenue margins while maintaining compliance.